however, because of their longer half-life and larger dose range, Semaglutide has demonstrated superior weight reduction effectiveness
Patients who shouldnt use compounded GLP-1 therapy include those who have a family history of specific cancers, including medullary thyroid cancer, or who have a rare disorder called multiple endocrine neoplasia type 2 syndrome
Patients with chronic diabetes are more likely to suffer cognitive impairment, and a number of neurodegenerative disorders, including Alzheimers Disease (AD), Parkinsons Disease and other forms of dementia
Where did the GLP-1 microdosing trend come from
While you do need to refrigerate unopened pens, the fact that you can keep your pen at room temperature after you start using it makes life much easier
However, individual experiences vary considerablysome people notice appetite changes earlier, while others enjoy sustained suppression into week 5